Targeted integration enables predictable clonal cell lines, enhancing transgene control and accelerating biopharma cell line development.
Fei Chen
Advertisement
Fei Chen, PhD, is head, Cell Line Development, at WuXi Biologics.
Articles by Fei Chen
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
2
Charles River Incubator Cohort to Accelerate CGT Development
3
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
4
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
5
